Manufacturing company IDEX (NYSE:IEX) will be reporting earnings tomorrow after market hours. Here’s what to expect.
IDEX beat analysts’ revenue expectations by 0.8% last quarter, reporting revenues of $798.2 million, flat year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ adjusted operating income estimates but a slight miss of analysts’ organic revenue estimates.
Is IDEX a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting IDEX’s revenue to grow 10% year on year to $868.1 million, a reversal from the 2.7% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.03 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. IDEX has missed Wall Street’s revenue estimates six times over the last two years.
Looking at IDEX’s peers in the gas and liquid handling segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Standex delivered year-on-year revenue growth of 6.4%, beating analysts’ expectations by 0.5%, and Parker-Hannifin reported a revenue decline of 1.6%, falling short of estimates by 1.1%. Standex traded down 2.2% following the results while Parker-Hannifin was up 6.3%.
Read our full analysis of Standex’s results here and Parker-Hannifin’s results here.
Investors in the gas and liquid handling segment have had steady hands going into earnings, with share prices flat over the last month. IDEX is up 7.2% during the same time and is heading into earnings with an average analyst price target of $235.38 (compared to the current share price of $224.31).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。